Log in to search using one of your social media accounts:

 

Baxter Issues A Voluntary Nationwide Recall For One Lot of Nexterone Injection Due To Presence Of Particulate Matter
Baxter International Inc. announced today it is voluntarily recalling one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection – distributed between 6/23/2017 and 10/2/2017 in the United States to wholesalers/distributors and healthcare facilities – due to the potential presence of particulate matter. The particulate matter may have entered the solution during the manufacturing process. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 14, 2017 Category: Food Science Source Type: news

NOAC-Drug Interactions Linked to Increased Bleeding NOAC-Drug Interactions Linked to Increased Bleeding
Concurrent use of amiodarone, fluconazole, rifampin, and phenytoin was associated with increased risk for major bleeding compared with the use of NOACs alone in a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 6, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

FDA Drug Safety Communication: Connection problems involving certain needleless pre-filled glass syringes containing adenosine and amiodarone
[05-06-2011] The U.S. Food and Drug Administration (FDA) is alerting the healthcare community about syringe connection problems when certain needleless glass syringes containing the cardiac drugs adenosine and amiodarone are used with particular types of intravenous (IV) access systems. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 4, 2017 Category: Drugs & Pharmacology Source Type: news

Research Analysis of Using tPA to Treat Cardiac Arrest
James and his friend Brandon, a 41-year-old male with an initially unknown past medical history, are hanging out when Brandon goes into cardiac arrest just outside of his house. James calls 9-1-1 and begins CPR until EMS arrives. James tells the arriving crew his friend could be hypoglycemic, so the lead paramedic administers an ampule of D50. A supraglottic airway is placed and compressions are continued, with end-tidal carbon dioxide (EtCO2) through the supraglottic device noted to be in the 30s. The crew also sees Brandon is in v fib, so they shock him with 200 joules and administer 3 mg epinephrine. He's transported to...
Source: JEMS Patient Care - February 26, 2017 Category: Emergency Medicine Authors: Amanda Polsinelli, MD Tags: Cardiac & Resuscitation Source Type: news

Research Highlights from NAEMSP Annual Meeting Presented at EMS Today 2017
The National Association of EMS Physicians (NAEMSP) Annual Meeting is one of the foremost forums to encourage, share and expand research in EMS and prehospital care. Paul Rostykus, MD, MPH, the immediate past program committee chair, who orchestrated the 2016 and 2017 NAEMSP meetings, presented a summary at EMS Today 2017 of the top research from the 2017 NAEMSP Annual Meeting held in New Orleans last month. Rostykus highlighted the award-winning abstracts from the 2017 NAEMSP annual meeting and the ever-popular Top Five Articles presentation. Five of the first six oral presentations of the top-judged abstracts covered car...
Source: JEMS Administration and Leadership - February 25, 2017 Category: Emergency Medicine Authors: JEMS Staff Tags: Administration and Leadership EMS Today Source Type: news

Corey Slovis Presents Important Clinical Articles at EMS Today 2017
Keeping up with the ever-increasing medical literature that is directly applicable to EMS is growing more difficult each day. More and more journals in more and more specialties are publishing articles that affect our care in the field. At EMS Today 2017, Dr. Corey Slovis—who chairs the department of emergency medicine at Vanderbilt University Medical Center and is medical director of the Nashville fire department and international airport—presented a number of potentially practice-changing articles in his session, The Most Important Published Articles for EMS Providers. Slovis discussed the recent New England ...
Source: JEMS Patient Care - February 23, 2017 Category: Emergency Medicine Authors: JEMS Staff Tags: Patient Care EMS Today Source Type: news

Friday Highlights: 2017 EMS State of the Science Gathering of Eagles XVIX
The 19th Annual EMS State of the Science: Gathering of Eagles Conference, “dedicated to the men and women of EMS who advocate daily for the sick and injured,” began today, packed with 85 topics, faculty and attendees ready to dive into and learn about the latest in EMS and prehospital care. The conference began at 7:30 a.m. with the conference overview and philosophy presented by Raymond L. Fowler, MD—officially dubbed “The First Eagle”—and course coordinator, Paul E. Pepe, MD, MPH. Top 5 Studies of the Year The conference began with a customary review of “The Five Most Important ...
Source: JEMS: Journal of Emergency Medical Services News - February 17, 2017 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: News Administration and Leadership Source Type: news

Friday Highlights: 2017 EMS State of the Science Gathering of Eagles XVIX
The 19th Annual EMS State of the Science: Gathering of Eagles Conference, “dedicated to the men and women of EMS who advocate daily for the sick and injured,” began today, packed with 85 topics, faculty and attendees ready to dive into and learn about the latest in EMS and prehospital care. The conference began at 7:30 a.m. with the conference overview and philosophy presented by Raymond L. Fowler, MD—officially dubbed “The First Eagle”—and course coordinator, Paul E. Pepe, MD, MPH. Top 5 Studies of the Year The conference began with a customary review of “The Five Most Important ...
Source: JEMS Administration and Leadership - February 17, 2017 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: News Administration and Leadership Source Type: news

Oklahoma's Data-Driven Approach to Urban EMS Response Time Reform
The Olympic motto is citius, altius, fortius (Latin for "faster, higher, stronger"). Although the 2016 Summer Games are long behind us, isn't a similar expectation always applied to "Team EMS"? We're expected to be faster in our response times, higher in our emergency care standards and stronger in our knowledge. Improving emergency care standards has helped EMS become more integral, effective and essential to a community's health—but what about response times? Is faster really better? Is it better in all circumstances? Is it better in any circumstance? Is there a cost to a fast(er) resp...
Source: JEMS Operations - February 1, 2017 Category: Emergency Medicine Authors: Jeffrey M. Goodloe, MD, NREMT-P, FACEP Tags: Ambulances & Vehicle Ops Communications Dispatch Source Type: news

Oklahoma's Data-Driven Approach to Urban EMS Response Time Reform
The Olympic motto is citius, altius, fortius (Latin for "faster, higher, stronger"). Although the 2016 Summer Games are long behind us, isn't a similar expectation always applied to "Team EMS"? We're expected to be faster in our response times, higher in our emergency care standards and stronger in our knowledge. Improving emergency care standards has helped EMS become more integral, effective and essential to a community's health—but what about response times? Is faster really better? Is it better in all circumstances? Is it better in any circumstance? Is there a cost to a fast(er) resp...
Source: JEMS Administration and Leadership - February 1, 2017 Category: Emergency Medicine Authors: Jeffrey M. Goodloe, MD, NREMT-P, FACEP Tags: Ambulances & Vehicle Ops Communications Dispatch Source Type: news

Experts query treatment of mild hypothyroidism in pregnancy
It cuts pregnancy loss but is linked to preterm delivery, gestational diabetes and pre-eclampsia Related items fromOnMedica New guidelines on epilepsy in pregnancy Diabetes in pregnancy Carcinoma of the thyroid Amiodarone: thyroid monitoring (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 25, 2017 Category: UK Health Source Type: news

Nexterone (Amiodarone HCl Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 28, 2016 Category: Drugs & Pharmacology Source Type: news

Spontaneous Circulation: Rebellions of the Heart: The End of Amiodarone
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - November 1, 2016 Category: Emergency Medicine Tags: Spontaneous Circulation Source Type: news

IV Amiodarone for WCT: Time to Say Goodbye? IV Amiodarone for WCT: Time to Say Goodbye?
Amiodarone has been the standard of care for wide complex tachycardia, but Dr Amal Mattu argues that it's time for this drug to be dethroned in favor of procainamide.Medscape Emergency Medicine (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 5, 2016 Category: Intensive Care Tags: Emergency Medicine Viewpoint Source Type: news

Hyperthyroidism: Too Much Of A Good Thing
By: Dr. Alan Christianson When someone you know is living with hypothyroidism, it can be tempting to think that if only the doctor would prescribe an extra helping of thyroid hormone, your friend or loved one would feel so much better and would enjoy life more. And in some cases, an extra helping might be in order. In other cases, not so much. Too much thyroid hormone can actually be dangerous, which is why doctors are loathe to bump the levothyroxin dosage up an extra 25 micrograms or so for one of their patients who's still experiencing hypothyroid symptoms. Tests always come first, and there's a good reason for that....
Source: Healthy Living - The Huffington Post - July 18, 2016 Category: Consumer Health News Source Type: news

Cordarone (Amiodarone HCl Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 9, 2016 Category: Drugs & Pharmacology Source Type: news

The VANISH Trial Should Not Vanquish Good Decision MakingThe VANISH Trial Should Not Vanquish Good Decision Making
Dr Mandrola asks readers to go beyond the top-line finding that catheter ablation bested escalated medical therapy with amiodarone when discussing options for patients with ischemic cardiomyopathy and VT. theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2016 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

VANISH: Ablation for Recurrent VT Bests Intensified AmiodaroneVANISH: Ablation for Recurrent VT Bests Intensified Amiodarone
UPDATED // Catheter ablation reduced the primary outcome compared with aggressive drug therapy and should be the preferred treatment in this population, the authors said. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 5, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

Pacerone (Amiodarone HCl Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 21, 2016 Category: Drugs & Pharmacology Source Type: news

ALPS: No Overall Survival Increase From Amiodarone, LidocaineALPS: No Overall Survival Increase From Amiodarone, Lidocaine
Although no benefit was found in the full group assessed, subgroup analysis showed significantly improved survival rates for both drugs vs placebo in those with witnessed out-of-hospital cardiac arrest. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. The r...
Source: JEMS Patient Care - April 5, 2016 Category: Emergency Medicine Tags: General News Cardiac & Resuscitation Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. The r...
Source: JEMS Patient Care - April 5, 2016 Category: Emergency Medicine Tags: News Cardiac & Resuscitation Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. The r...
Source: JEMS: Journal of Emergency Medical Services News - April 5, 2016 Category: Emergency Medicine Tags: News Cardiac & Resuscitation Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. T...
Source: JEMS Patient Care - April 5, 2016 Category: Emergency Medicine Tags: News Cardiac & Resuscitation Source Type: news

Study: Antiarrhythmic drugs save lives in out-of-hospital cardiac arrest
Stephen FellerBETHESDA, Md., April 4 (UPI) -- If used soon after sudden cardiac arrest, the drugs amiodarone and lidocane could save as many as 1,800 lives per year, according to a recent study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 4, 2016 Category: Consumer Health News Source Type: news

FDA Drug Safety Communication: Connection problems involving certain needleless pre-filled glass syringes containing adenosine and amiodarone
[05-06-2011] The U.S. Food and Drug Administration (FDA) is alerting the healthcare community about syringe connection problems when certain needleless glass syringes containing the cardiac drugs adenosine and amiodarone are used with particular types of intravenous (IV) access systems. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 4, 2016 Category: Drugs & Pharmacology Source Type: news

Ablation and Meds Comparable to Reduce ICD Shocks
(MedPage Today) -- Only amiodarone tied to fewer tachycardias, but it also increased mortality (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 9, 2016 Category: Cardiology Source Type: news

Thyrotoxicosis Associated With the Use of AmiodaroneThyrotoxicosis Associated With the Use of Amiodarone
What role could imaging play in differentiating type 1 from type 2 amiodarone-induced thyrotoxicosis? Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 8, 2016 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

EMS State of the Science: A Gathering of Eagles XVIII
This is a brief, encapsulated report by JEMS editor-in-chief A.J. Heightman from the Eagles conference. He recommends that you go to www.gatheringofeagles.us  after the conference to download and read the full presentation slides, background, research and recommendations, and that you receive your medical director’s approval before implementing any changes to your protocols and care practices. Friday, Feb. 19, 2016               Paul E. Pepe, MD, MPH, Eagles Conference course coordinator, opened the 18th annual conference by introducing Dr. Corey Slovis, who was recently awarde...
Source: JEMS Administration and Leadership - February 19, 2016 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: News Administration and Leadership EMS Today Source Type: news

EMS State of the Science: A Gathering of Eagles XVIII
This is a brief, encapsulated report by JEMS editor-in-chief A.J. Heightman from the Eagles conference. He recommends that you go to www.gatheringofeagles.us  after the conference to download and read the full presentation slides, background, research and recommendations, and that you receive your medical director’s approval before implementing any changes to your protocols and care practices. Friday, Feb. 19, 2016               Paul E. Pepe, MD, MPH, Eagles Conference course coordinator, opened the 18th annual conference by introducing Dr. Corey Slovis, who was recently awarde...
Source: JEMS: Journal of Emergency Medical Services News - February 19, 2016 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: News Administration and Leadership EMS Today Source Type: news

EMS State of the Science: A Gathering of Eagles XVIII
This is a brief, encapsulated report by JEMS editor-in-chief A.J. Heightman from the Eagles conference. He recommends that you go to www.gatheringofeagles.us  after the conference to download and read the full presentation slides, background, research and recommendations, and that you receive your medical director’s approval before implementing any changes to your protocols and care practices. Friday, Feb. 19, 2016               Paul E. Pepe, MD, MPH, Eagles Conference course coordinator, opened the 18th annual conference by introducing Dr. Corey Slovis, who was recently awarde...
Source: JEMS Administration and Leadership - February 19, 2016 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: News Administration and Leadership Source Type: news

Oct 9 Cardiology News Oct 9 Cardiology News
Possible aortic-valve thrombosis, coronary calcium, amiodarone, remote ischemic preconditioning, cancer and the heart are topics for this week's podcast with John Mandrola theheart.org on Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 9, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news

Amiodarone Confers a Small Risk for Optic NeuropathyAmiodarone Confers a Small Risk for Optic Neuropathy
Physicians should monitor visual symptoms in amiodarone users. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2015 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

ED sedation with droperidol is relatively safe and effective
This study has shown that droperidol is relatively safe and effective for the management of violent and aggressive patients in the ED and that there was no increased risk of QT prolongation and torsades de points according to a large cohort of cases.” The “Editor’s Capsule Summary” that accompanies the article is even more emphatic*: How this is relevant to clinical practice Droperidol is safe even with the high doses used in this study. The authors note that the study does not rule out that droperidol may be associated with rare cases of torsades. But the agitated, delirious ED patient may be a dan...
Source: The Poison Review - May 20, 2015 Category: Toxicology Authors: Leon Tags: Best of TPR Medical black box warning droperidol FDA food and drug administration QT prolongation torsades de pointes Source Type: news

Your NEJM Group Today: Amiodarone & Vortex Keratopathy, Antibiotics & Overweight Toddlers, Connecticut IM Opportunity (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today: … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 27, 2015 Category: Primary Care Source Type: news

EMA: Heart Risk From Amiodarone Plus Hepatitis C AntiviralsEMA: Heart Risk From Amiodarone Plus Hepatitis C Antivirals
The caution applies to several medications with sofosbuvir, used to fight hepatitis C; the caution in Europe mirrors similar antiviral labeling changes announced by the US FDA within the past month. News Alerts (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 24, 2015 Category: Internal Medicine Tags: Cardiology News Alert Source Type: news

EU regulators warn against combining hepatitis C drugs with amiodarone
(Reuters) - European health regulators warned on Friday against using Gilead Sciences Inc's and Bristol-Myers Squibb Co's hepatitis C medicines along with amiodarone, a drug used to regulate the heartbeat of people with heart rhythm disorders. (Source: Reuters: Health)
Source: Reuters: Health - April 24, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

HCV Antiviral Simeprevir Label Warns of Cardiac RiskHCV Antiviral Simeprevir Label Warns of Cardiac Risk
The approved labeling change from the FDA warns of an increased risk of bradycardia with simeprevir when it is used in combination with amiodarone and sofosbuvir. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2015 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Could the HCV Drug Sofosbuvir Be Cardiotoxic? Could the HCV Drug Sofosbuvir Be Cardiotoxic?
The FDA warning about a potential interaction between amiodarone and the new HCV drugs Sovaldi/Harvoni prompts Dr John Mandrola to wonder if the problem may lie with the antivirals. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 31, 2015 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

FDA Warns of Cardiac Effect When Heart Drug Mixed With Hepatitis C Meds
Adding Harvoni or Sovaldi to amiodarone could cause dangerous slowing of heart rate, agency says (Source: WebMD Health)
Source: WebMD Health - March 25, 2015 Category: Consumer Health News Source Type: news

FDA Warns of Cardiac Effect When Heart Drug Mixed with Hepatitis C Meds
Adding Harvoni or Sovaldi to amiodarone could cause dangerous slowing of heart rate, agency says Source: HealthDay Related MedlinePlus Pages: Arrhythmia, Drug Reactions, Hepatitis C (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 25, 2015 Category: Consumer Health News Source Type: news

Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Drug Safety Communication - Serious Slowing of Heart Rate When Used With Antiarrhythmic Drug Amiodarone
Postmarketing cases of serious and life-threatening symptomatic bradycardia, as well as one fatal cardiac arrest and cases requiring pacemaker insertion, have been reported. (Source: FDA MedWatch)
Source: FDA MedWatch - March 24, 2015 Category: American Health Source Type: news

Gilead stock drops on hepatitis C drug's heart warning
Gilead Sciences Inc., which warned doctors and other health-care providers late last week not to use its groundbreaking hepatitis C drugs with patients on a well-known heart medication, saw its stock drop 2 percent in trading Monday. The Foster City-based drug developer (NASDAQ: GILD) said one patient taking its drugs Harvoni or Sovaldi as well as the heart drug amiodarone died of cardiac arrest and three required a pacemaker. In all, the company said, nine patients developed abnormally slow heartbeats. Amiodarone,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 24, 2015 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

FDA: Bradycardia Risk With Amiodarone Plus Hep-C AntiviralsFDA: Bradycardia Risk With Amiodarone Plus Hep-C Antivirals
The FDA is updating labeling for Harvoni and Savoldi antivirals after the death of one patient, and pacemaker implantation in three others, who were also on the antiarrhythmic agent. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 23, 2015 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Gilead shares dip after warning about hepatitis C drug interaction
(Reuters) - Gilead Sciences Inc shares slid 2 percent on Monday after the company warned about potentially fatal risks for patients being treated with its top-selling hepatitis c drugs who also take the potent heart drug amiodarone. (Source: Reuters: Health)
Source: Reuters: Health - March 23, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Gilead's Hepatitis Drugs Tripped By Old Heart Drug
Late last week Gilead Sciences issued a warning about a rare but potentially fatal interaction between its stellar new hepatitis C drug sofosbuvir and amiodarone, a potent but tricky antiarrhythmic agent. Sofosbuvir is marketed as Sovaldi and, in combination with another antiviral agent, as Harvoni. Amiodarone, which is used to treat dangerous heart rhythm problems, has a number of different side effects and an extremely long half-life. Its use is generally reserved for difficult cases. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 23, 2015 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Ablation Bests Amiodarone for Treating AF in Patients with Heart FailureAblation Bests Amiodarone for Treating AF in Patients with Heart Failure
Evidence on AF ablation in HF is in short supply, and "This is a reasonably sized trial that makes this comparison of ablation vs a drug. And clearly, ablation is better," says one expert. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news

ACC: Ablation Beats Amiodarone for Afib in HF (CME/CE)
(MedPage Today) -- Fewer recurrences of atrial fibrillation, reduced hospitalization, and better survival. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 18, 2015 Category: Cardiology Source Type: news

Heart failure patients fare better with catheter ablation than Amiodarone
Among patients with heart failure and atrial fibrillation, those who underwent catheter ablation were less likely to die, be hospitalized or have recurrent atrial fibrillation than patients taking a heart rhythm regulating drug, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 16, 2015 Category: Science Source Type: news